Shares of Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of GBX 186.65 and traded as high as GBX 191.90. Faron Pharmaceuticals Oy shares last traded at GBX 191.90, with a volume of 4,968 shares trading hands.
Faron Pharmaceuticals Oy Price Performance
The stock has a market cap of £218.58 million, a price-to-earnings ratio of -7.11 and a beta of 0.36. The company has a debt-to-equity ratio of 922.55, a quick ratio of 1.09 and a current ratio of 1.45. The company has a 50-day simple moving average of GBX 186.65 and a two-hundred day simple moving average of GBX 203.60.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Read More
- Five stocks we like better than Faron Pharmaceuticals Oy
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- 5 Top Rated Dividend Stocks to Consider
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
